NYSE Euronext today announced the listing of MEDIAN Technologies, a provider of software and services specialized in clinical and diagnostic applications that use medical imaging in oncology, on NYSE Alternext in Paris.
Founded in 2002, MEDIAN Technologies is a software developer and service provider, specialized in clinical solutions that make use of medical imaging. Its applications help radiologists, oncologists, and more generally all specialists who prescribe radiological exams to read, detect, quantify and track test results. The company has a staff of 40, more than half of whom work in R&D, and has a subsidiary in the USA.
MEDIAN Technologies (ticker code: ALMDT) was listed through admission to trading of 5,588,838 existing shares including 1,239,356 new shares issued in a private offering to qualified investors. The total amount raised was €9.98 million.
The admission and issue price of MEDIAN Technologies shares was set at €8.05. Market capitalization stood at €45 million on the day of listing.